Impact of Pharmaceutical Care Interventions on Health Outcomes of Patients With Type 2 Diabetes Mellitus in Yobe State University Teaching Hospital

Summary

Brief Summary:

Many people with diabetes in Nigeria have trouble controlling their blood sugar. This can lead to serious health problems such as heart disease, kidney damage, eye problems, and nerve pain. Medicines alone are often not enough if patients do not take them correctly, understand how to use them, or make healthy lifestyle changes.

This study looks at whether extra support from a pharmacist can help patients with type 2 diabetes mellitus get better health results. The study is being done at Yobe State University Teaching Hospital in Nigeria.

What the study is about:

The investigators want to find out if a special "pharmaceutical care" program run by a pharmacist can improve participants' blood sugar control and overall health compared to the usual care they receive in the hospital.

What participants will do:

Participants who agree to join the study will be divided into two groups by chance.

One group will receive the normal diabetes care from doctors and nurses. The other group will receive normal care plus regular meetings with a trained pharmacist.

In the pharmacist sessions, participants will get:

Clear explanations about their diabetes medicines (why they are needed, how and when to take them, and possible side effects).

Help to solve any problems with taking medicines correctly. Simple advice on healthy eating, physical activity, and checking blood sugar at home.

Regular follow-up to answer questions and check progress.

No new or experimental drugs are being tested. No injections, surgeries, or invasive procedures are involved. Patients continue with their usual diabetes medicines prescribed by their doctors.

Why this matters:

If the pharmacist support helps patients control their blood sugar better and feel healthier, it could be a simple and useful way to improve diabetes care in hospitals like ours. Better control can reduce the risk of serious complications and improve quality of life for patients and their families.

The study will measure changes in blood sugar levels (HbA1c), blood pressure, how well patients take their medicines, and how they feel about their health. Investigators will compare the two groups after several months.

This research does not involve any risk beyond the usual care patients already receive. Participation is voluntary, and patients can leave the study at any time without affecting their normal treatment.

Conditions

• Type 2 Diabetes

Interventions

BEHAVIORAL

Pharmaceutical Care

1. Review and optimization of prescriptions to ensure safe and effective therapy 2. Identification and resolution of drug therapy problems (DTPs) 3. Clarification of medication usage and disease-related questions, offering tailored support based on patient-specific challenges 4. Education on prevention and management of diabetes-related complications 5. Hands-on training on the use of Self-Monitoring of Blood Glucose (SMBG) devices 6. Provision of monthly blood glucose logbooks (Appendix VII) 7. Interpretation of blood glucose values to enhance patient engagement and monitoring 8. Individual counselling sessions addressing psychosocial and behavioural concerns 9. Personalized dietary guidance tailored to each patient's needs 10. Distribution of diabetes infographic leaflets to reinforce learning and promote adherence

BEHAVIORAL

Usual Care

Physician consultation, routine laboratory investigation, prescription refill

Sponsors & Collaborators

• University of Maiduguri

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2024-02-01

Primary Completion

2025-05-30

Completion

2025-05-31

Countries

• Nigeria

Study Locations